Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Nippon Express (India) Newly Acquires GDP Certification at Three Locations 2021-07-08 15:00
BioShin Expands Senior Leadership Team: Sarah Lu Joins BioShin as Chief Medical Officer, Mary Ma Joins BioShin as Chief Commercial Officer 2021-07-08 12:01
Harbour BioMed Reports Positive Topline Results from Phase 2 Trial of Batoclimab (HBM9161) in Generalized Myasthenia Gravis 2021-07-06 21:06
Bionomics Initiates Phase 2b ATTUNE Study of BNC210 in PTSD 2021-07-06 18:00
Transcenta Provides Program Update for Anti-Claudin18.2 Monoclonal Antibody TST001 and Reports Promising Early Anti-Tumor Responses in Patients with Gastric Cancer 2021-07-02 21:02
I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio 2021-07-01 20:00
Alterity Therapeutics granted a new US patent targeting major neurodegenerative diseases including Alzheimer's and Parkinson's 2021-07-01 19:50
Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs 2021-06-30 22:00
I-Mab Honored with Top Rankings by Institutional Investor 2021-06-30 20:00
Akeso Awarded as 2021 "Most Honored Company" by Institutional Investor 2021-06-30 16:00
OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies 2021-06-30 09:29
I-Mab Announces Upcoming Participation at July Conference 2021-06-29 20:00
Lianhua Qingwen Granted Market Access as Medicine in Ukraine: Yiling Pharmaceutical 2021-06-29 16:41
First in China! Neurophth announced the first patient has been dosed in G.O.L.D. clinical trial for the gene therapy treatment of LHON 2021-06-28 21:33
ILIAS Biologics Inc. demonstrated the therapeutic effect of anti-inflammatory exosomes for ischemia-reperfusion-induced acute kidney injury 2021-06-28 20:00
InnoCare Announces Breakthrough Therapy Designation of Orelabrutinib by US FDA for Treatment of R/R MCL 2021-06-28 16:02
Sanyou Biopharmaceuticals completes series B financing and secures its leading role in innovative antibody drug discovery 2021-06-26 23:00
I-Mab Announces China NMPA Approval for Phase 1b Trial of Felzartamab in Systemic Lupus Erythematosus 2021-06-25 20:00
InnoCare Announces Approval of Initiation of Phase 1 Clinical Trial of RTK Inhibitor ICP-033 in China 2021-06-25 19:04
Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture 2021-06-25 12:57
1 108 109 110 111 112 171